Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2026-03-03 @ 2:27 PM
Study NCT ID:
NCT05029102
Status:
RECRUITING
Last Update Posted:
2024-02-12
First Post:
2021-08-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TAS-102 and Anlotinib in ≥3 Lines mGC
Sponsor:
Zhejiang University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Gastric Cancer | View |
Keywords: